التفاصيل البيبلوغرافية
| العنوان: |
Pembrolizumab With or Without Lenvatinib for First-Line Metastatic NSCLC With Programmed Cell Death-Ligand 1 Tumor Proportion Score of at least 1% (LEAP-007): A Randomized, Double-Blind, Phase 3 Trial |
| المؤلفون: |
Yang, James Chih-Hsin, Han, Baohui, De La Mora Jiménez, Emmanuel, Lee, Jong-Seok, Koralewski, Piotr, Karadurmus, Nuri, Sugawara, Shunichi, Livi, Lorenzo, Basappa, Naveen S., Quantin, Xavier, Dudnik, Julia, Ortiz, Diego Moran, Mekhail, Tarek, Okpara, Chinyere E., Dutcus, Corina, Zimmer, Zachary, Samkari, Ayman, Bhagwati, Niyati, Csőszi, Tibor |
| المصدر: |
Journal of Thoracic Oncology ; ISSN 1556-0864 |
| بيانات النشر: |
Elsevier BV |
| سنة النشر: |
2023 |
| المجموعة: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: |
Pulmonary and Respiratory Medicine, Oncology |
| نوع الوثيقة: |
article in journal/newspaper |
| اللغة: |
English |
| DOI: |
10.1016/j.jtho.2023.12.023 |
| الإتاحة: |
https://doi.org/10.1016/j.jtho.2023.12.023Test
https://api.elsevier.com/content/article/PII:S1556086423024322?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1556086423024322?httpAccept=text/plainTest |
| حقوق: |
https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by-nc-nd/4.0Test/ |
| رقم الانضمام: |
edsbas.97C1627E |
| قاعدة البيانات: |
BASE |
